H1B Salary Data

Home › Employers › Clover Health, LLC.

Clover Health, LLC.: H-1B salaries and sponsorship

Clover Health, LLC. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $160,000.

Applications (LCAs)3
Certified3
Employer addressJersey City, NJ
H-1B dependent employerNo
Median offered salary$160,000
Middle half of salaries$125,000–$165,000
10th–90th percentile$104,000–$168,000

Does Clover Health, LLC. sponsor H-1B visas?

Clover Health, LLC. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 11, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Customer Success Associate1$90,000
Data Platform Engineer III1$160,000
Special Projects Lead, Innovation & Delivery1$170,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20252$125,000
FY20261$170,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Special Projects Lead, Innovation & Delivery$170,000–$210,000
Level II
New York, NYJun 11, 2026Jun 22, 2026Certified
Data Platform Engineer III$160,000
Level III
Lewisville, TXJul 24, 2025Aug 4, 2025Certified
Customer Success Associate$90,000
Level I
Harrison, NJMay 14, 2025Oct 1, 2025Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).